Effets arythmogènes du chlorydrate de sultopride : corrélation clinique et électrophysiologique cellulaire

Gilles Lande(Inserm), Hervé Le Marec(Centre National de la Recherche Scientifique), Emmanuel Drouin(Groupe Hospitalier de l'Institut Catholique de Lille), Anne Chiffoleau, Charles Gauthier(Université du Québec à Chicoutimi), J. C. Chevallier(Hôpital Laennec), Jeanne Godin(Hôpital Laennec)
Annales Françaises d Anesthésie et de Réanimation
January 1, 1992
10.1016/s0750-7658(05)80782-8
Cited by 20

Related Papers

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
|Heart Rhythm|2011|1.5k
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death
|Nature|2003|961
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
|EP Europace|2011|904
Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome
|Circulation|2010|850
Cardiac conduction defects associate with mutations in SCN5A
|Nature Genetics|1999|638